Placebo for MK-8150

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HypertensionIsolated Systolic HypertensionIsolated Systolic Hypertension (ISH)

Phase 1

A Single Rising Dose Study of MK-8150 (MK-8150-001)

CompletedNCT01590810

Merck Sharp & Dohme LLCHypertension, Isolated Systolic Hypertension (ISH)

Start: 2012-05-07End: 2013-02-05Updated: 2018-09-25

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)

CompletedNCT01656408

Merck Sharp & Dohme LLCHypertension, Isolated Systolic Hypertension

Start: 2012-08-01End: 2013-05-23Updated: 2018-09-25

Related Papers

Discovery and Clinical Evaluation of MK‐8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release

Journal of the American Heart Association2016-08-2615 citations